Scientists have developed a groundbreaking approach using specially designed peptides to improve drug formulations. This innovative method significantly enhances anti-tumor efficacy.

AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

The European Commission is investing in a groundbreaking quantum chip that will use Germanium-Silicon (GeSi) to combine light ...

Konstanz biologist Patrick Müller receives a Proof of Concept Grant from the European Research Council for his project "EmbryoNet-AI". Its goal is the further development of an AI-supported platform ...

Dr. Imbert brings 25 years of strategic clinical to commercial-stage manufacturing and drug development experienceSOUTH SAN FRANCISCO, Calif., ...

The Houston Police Department is addressing its overcrowded property room, which is attracting "drug-addicted rats." ...

Schrödinger, Inc. (Nasdaq: SDGR) today provided an update on its progress across the business in 2024 and announced its strategic priorities for 2025.

EYLEA HD® and EYLEA® remained the U.S. anti-VEGF category leader in 2024; aggregate U.S. net product sales were $6 billion for full-year 2024, up 1% based on preliminary (unaudited) results EYLEA HD ...

Police suspect the Rajasthan-based drug network is part of a larger international operation, possibly linked to cross-border trafficking. Recent arrests of two Jhalawar-based drug peddlers ...

PureTech Health said the Food and Drug Administration granted fast-track designation for a drug candidate to treat patients with acute myeloid leukemia. The biotherapeutics company said the ...